Drug Profile
Tumour necrosis factor-beta
Alternative Names: LymphotoxinLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Genentech
- Developer Kanegafuchi Chemicals
- Class Antihyperglycaemics; Antineoplastics; Antivirals; Cytokines; Tumour necrosis factors
- Mechanism of Action Immunomodulators; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Type 1 diabetes mellitus